Between 1991 and 1996, 268 patients were entered onto the study. Two hundred forty-three patients were assessable (127 RT + CT patients and 116 RT patients). Progression-free and overall survival are ...

Purpose: The primary objective of this phase I trial was to define the maximum-tolerated dose of external-beam radiation with concurrent fixed-dose continuous-infusion doxorubicin followed by surgical ...

Please provide your email address to receive an email when new articles are posted on . Androgen deprivation therapy sequencing had a considerable effect on outcomes among men with prostate cancer who ...

More than 90% of patients with locally advanced basal cell carcinoma (BCC) of the head and neck achieved locoregional control (LRC) with vismodegib (Erivedge) and radiation therapy (RT), a small ...

In many cancer types, cancer cells try to survive by escaping attack from the immune system. These cancer cells hijack mechanisms called immune checkpoints to trick the immune system into thinking ...

For patients with brain metastases, treatment with an antibody-drug conjugate (ADC) at the same time as stereotactic radiotherapy significantly raises the risk of symptomatic radiation necrosis, a new ...

Chimeric antigen receptor–T cell (CAR-T) therapy may effectively treat B-cell non-Hodgkin lymphoma (NHL) while also improving control of autoimmune disease in patients with both conditions. There was ...

PHILADELPHIA, PA – The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate ...

HONG KONG, Feb. 12, 2025 /PRNewswire/ — Akeso, Inc. (9926. HK) (“Akeso” or the “Company”) announced the recent completion of the first patient enrollment in the Phase 3 randomized, double-blind, ...